Comparison with other Solitaire patient series
| Present Study | Machi et al11 | Roth et al10 | Castaño et al9a | Stampfl et al12 | |
|---|---|---|---|---|---|
| Number of patients | 36 | 56 | 22 | 20 | 18 |
| CS or GA | CS | GA | Both | GA | GA |
| Baseline NIHSS score | 17.1 | 15.8 | 19.4 | 19 | 21 |
| ASPECT score | 6.6 | – | – | – | – |
| Symptom onset to recanalization (min) | 302 | 353 | 277 | 352 | 289 |
| Successful recanalization | 77.8%c | 89%d | 90.9%c | 90%d | 88%c |
| NIHSS score at discharge | 9 | 7 | – | 9.4 | – |
| Symptomatic ICHb | 8.3% | 1.7% | 13.6% | 10%e | 16.6% |
| mRS ≤2 at 3 months | 61.1% | 46% | 50% | 45% | 33.30%e |
| Mortality at 3 months | 22.2% | 7.1%e | 18.1% | 20% | 33%e |
Note:—We show our results with mean in order to favor comparison with other series. Only the Castaño et al9 results are presented with median. CS indicates conscious sedation; GA, general anesthesia; ICH, intracranial hemorrhage; min, minutes.
a In this series, the Solitaire device was not always used alone (3 times after the Merci device and twice after intra-arterial tissue plasminogen activator).
↵b Depicted on CT (at 24 hours).
↵c Defined by TICI ≥2a.
↵d Defined by TICI ≥2b.
↵e Evaluation was done at discharge.